Since we could show that phosphorylation of MLH1 switches off MMR in vitro [9], we next tested in vivo if high CK2α expression—which we could verify to induce high p-MLH1-levels—is responsible for higher mutation rates in corresponding tumor tissue. This evidence concerns the gene MLH1 and neoplasm.